-

Global Sleep Tech Devices Market Growth, Trends, and Forecasts Report 2020-2025 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Sleep Tech Devices Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.

The Sleep Tech Devices market is expected to register a CAGR of 15.5% over the forecast period. The major factors attributed to the market growth include rising burden of sleep disorders and technological advancements.

According to the Journal of Family Medicine and Primary Care, 2016, insomnia is often associated with diabetes and increasing age, with the prevalence of it about 33%. Furthermore, in 2017, around 22 million people in the United States were found to be suffering from sleep apnea as per the data of Sleep Apnea Organization. Also, in 2019, Philips launched a "Philips Nightbalance," a sleep therapy device which is specially designed for positional obstructive sleep apnea patients. Thus, the higher prevalence of sleep disorders is expected to increase the demand for sleep tech devices.

Key Market Trends

Wearables Segment is Expected to Exhibit a Significant Market Growth in the Sleep Tech Devices Market

Wearable segment is expected to show lucrative growth in the sleep tech devices market. The adoption of sedentary lifestyles may play a crucial role in sleeping health. Wearable devices help an individual to track the sleeping pattern.

According to the study of International Journal of Environmental Research and Public Health, 2018, wearable trackers showed closer approximation to sleep outcomes and offer a low-cost alternative to conventional devices.

In 2019, Samsung introduced a new Fitbit in the market that tracks sleep data. Therefore, with the rising adoption of wearable sleep tech devices, it is expected to positively influence the market growth.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to be a dominant region in the Sleep Tech Devices market owing to a rising geriatric population and the higher prevalence of sleeping disorders. Older adults are at higher risk of insomnia. According to the National Sleep Foundation, in 2018, around 44% of adults (aged 65 and above) were diagnosed with some kind of sleep disorder. As per the data of Sleep Zone, 2018, 22 million people in the United States were found to be suffering from obstructive sleep apnea. Hence, these factors are expected to influence positively on the market growth in this region.

Competitive Landscape

Companies are taking initiatives to grow their presence in the market. In 2019, ProSomnus Sleep Technologies designed a sleep apnea device that offers precision Continuous Advancement in Sleep Apnea Device.

Key players that are expected to be dominant in Sleep Tech Devices market are Eight Sleep, Phillips, Dodow, Casper, Compumedics, Sleep Shepherd, Sleepace, Xiaomi, Oura Health and Nihon Kohden Corporation, Inc.

Key Topics Covered:

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Increasing Prevalence of Sleep Disorders

4.2.2 Technological Advancements

4.3 Market Restraints

4.3.1 High Cost of Sleep Tech Devices

4.4 Porter's Five Force Analysis

5 MARKET SEGMENTATION

5.1 By Product

5.1.1 Wearables

5.1.1.1 Smart Watches and Bands

5.1.1.2 Others

5.1.2 Non-Wearables

5.1.2.1 Sleep Monitors

5.1.2.2 Beds

5.1.2.3 Others

5.2 By End-User

5.2.1 Hospitals

5.2.2 Home-care Settings

5.2.3 Others

5.3 Geography

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

6.1.1 Casper

6.1.2 Compumedics

6.1.3 Dodow

6.1.4 Eight Sleep

6.1.5 Nihon Kohden Corporation, Inc.

6.1.6 Oura Health

6.1.7 Phillips

6.1.8 Sleep Shepherd

6.1.9 Sleepace

6.1.10 Xiaomi

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/iyut4m

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Hexabromocyclododecane (CAS 25637-99-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Hexabromocyclododecane (CAS 25637-99-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. This report on Hexabromocyclododecane provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves as a v...

Commercial Gas Rice Cookers Market Report 2026: Revenues Set to Reach $2 Billion by 2032 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Commercial Gas Rice Cookers Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Commercial Gas Rice Cookers Market is experiencing significant growth, evolving from USD 1.28 billion in 2025 to an anticipated USD 2.00 billion by 2032, driven by a CAGR of 6.52%. This market research report provides a comprehensive analysis of the commercial gas rice cooker sector, highlighting key drivers like foodservice efficiency, industria...

Artemisinin Combination Therapy Market to Grow by $194 Million During 2026-2032 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Artemisinin Combination Therapy Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Artemisinin Combination Therapy (ACT) market exemplifies dynamic growth and promising potential in the treatment of malaria. Expected to increase from USD 386.40 million in 2025 to USD 608.26 million by 2032, supported by a steady CAGR of 6.69%, this market highlights the evolving landscape for modern antimalarial solutions. At the core of AC...
Back to Newsroom